Mackenzie Schuckman Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1107 E 13th St, Hays, KS 67601 Phone: 785-675-0043 Fax: 785-422-7521 |
Jennifer Sullivan Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 94 Lewis Dr, Hays, KS 67601 Phone: 785-625-3257 |
Marcy Beougher Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 600 Park St, Albertson 103c, Hays, KS 67601 Phone: 785-628-5366 |
Anne J Bemis, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 600 Park Street, Albertson Hall 103d, Hays, KS 67601 Phone: 785-628-5260 Fax: 785-628-5271 |
Mrs. Somary M Vilaysing, M.S. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 217 W 17th St, Hays, KS 67601 Phone: 785-639-0535 |
Kreative Speech Therapy, Llc Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2402 Centennial Blvd, Hays, KS 67601 Phone: 785-639-4603 |
Mrs. Glenda Susan Bowles, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 94 Lewis Dr, Hays, KS 67601 Phone: 785-625-3257 Fax: 785-625-8557 |
Phillip R Sechtem, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 600 Park St, Hays, KS 67601 Phone: 785-628-5366 Fax: 785-628-5271 |
Chloe Nicole Logan Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2213 Centennial Blvd, Hays, KS 67601 Phone: 720-480-7900 |
Jacque Lynn Jacobs Speech-Language Pathologist Medicare: Accepting Medicare Assignments Practice Location: 2401 Canterbury Dr, Hays, KS 67601 Phone: 785-628-3241 |
Blake Roth Speech-Language Pathologist Medicare: Accepting Medicare Assignments Practice Location: 600 Park St, Hays, KS 67601 Phone: 785-628-5366 |
Amy Marie Sterling, M.S. CCC-SLP Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 600 Park St, Herndon Clinic- Albertson Hall, Hays, KS 67601 Phone: 785-628-3478 |
Abigail Alyssa Rohr, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 94 Lewis Dr, Hays, KS 67601 Phone: 785-625-3257 |
Jana E. Johnson, M.S. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 600 Park St, Hays, KS 67601 Phone: 785-628-4606 Fax: 785-628-5271 |
Marla S. Staab, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 600 Park St, Albertson Hall 135, Hays, KS 67601 Phone: 785-628-4450 Fax: 785-628-5271 |
Katherine Mai, MS, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 94 Lewis Dr, Hays, KS 67601 Phone: 785-625-3257 |
Andrea Carmichael Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 600 Park St, Hays, KS 67601 Phone: 785-628-4000 |
Herndon Clinic Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 600 Park St, Herndon Clinic Albertson Hall 131, Hays, KS 67601 Phone: 785-628-5366 Fax: 785-628-5271 |
Dr. Carol Marie Ellis, PHD, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 600 Park St, Hays, KS 67601 Phone: 785-628-5366 |
Ryan Marie Walt, M.S. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 94 Lewis Dr, Hays, KS 67601 Phone: 785-625-3257 |
News Archive
Researchers at Wake Forest Baptist Medical Center are leading a four-year, $8.9 million national project to identify variations in the human genome and corresponding changes in the arterial proteins associated with premature development of atherosclerosis.
Revolutions Medical Corporation recently completed the reworking of a worldwide exclusive license with Traxyz, LLC for an image guided navigation system to convert over 50,000 conventional mammography systems for use as a high accuracy breast biopsies system (BBS). This BBS facilitates accurate and fast non-palpable lesions and micro calcification localization in the treatment of breast cancer.
On April 6, the U.S. Food and Drug Administration approved Horizant Extended Release Tablets, a once-daily treatment for moderate-to-severe restless legs syndrome.
USA Today reports that the Supreme Court's review could cause the the health law debate to stretch through the presidential campaign. Other media outlets take a look at what would happen without the individual mandate, and at stakeholders' positions related to the law's Medicaid expansion.
The U.S. Food and Drug Administration today announced draft guidance that would expand transparency and disclosure when the agency grants a conflict of interest waiver to permit an individual's participation at an FDA advisory committee meeting.
› Verified 4 days ago